Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Ubiquitin E1 inhibitor and preparation method thereof

A technology of inhibitors and ubiquitin, applied in the field of compounds of ubiquitin E1 inhibitors

Inactive Publication Date: 2011-02-02
西安杰诺瓦生物科技有限公司
View PDF1 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Moreover, according to the Lipinski regulation, the substance contains groups that are not ideal as drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ubiquitin E1 inhibitor and preparation method thereof
  • Ubiquitin E1 inhibitor and preparation method thereof
  • Ubiquitin E1 inhibitor and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0086] Example 1: Preparation of ubiquitin E1 inhibitor compounds and derivatives thereof

[0087] figure 2 Show the preparation method and technological process of present embodiment:

[0088] (a) prepare alkali-free hydrazine group, take phenylhydrazine as example (see scheme II):

[0089] Anhydrous sodium carbonate (0.015M) was added to 50ml of an aqueous solution containing 0.01M phenylhydrazine hydrochloride, and extracted three times with dichloromethane, 30ml each time, to obtain a solution. It was dried over anhydrous sodium carbonate and concentrated to release phenylhydrazine, which was used in subsequent synthesis without purification.

[0090] (b) Preparation of compound (iii), methyl-3-oxo-3-(N'-phenylhydrazino) propionic acid

[0091] Dissolve phenylhydrazine (5.94 g, 55 mM) in 100 ml dry THF and Et 3 H (8.11 ml, 58.3 mM). The mixed reaction was cooled to -10°C, and 50 ml of anhydrous THF containing methyl-3-chloro-3-oxo-propionic acid (7.12 ml, 56.6 mM) wa...

Embodiment 2

[0096] Example 2: Detection of ubiquitin E1 inhibitory effect of ubiquitin E1 inhibitor compounds and derivatives thereof

[0097]Experimental method: use DMEM / F-12 medium (Hyclone, logan, UT) (wherein containing 10% FCS, 0.3% sodium bicarbonate, 100U / ml penicillin, 100 μ g / ml streptomycin) to cultivate RPE cells for detection Ubiquitin E1 inhibitors penetrate into cells and bind intracellularly to the level of E1 ubiquitin complexes. The cells were seeded in a 12-well tissue culture plate and cultured overnight, and the cell confluency reached 85%. Incubate with DMSO, PYR-41 (50 μM) and compound (50 μM) for 30 minutes. Wash gently twice with PBS, add lysis buffer to scrape off the cells (lysis buffer: 5mM Tris-HCl, pH6.8, 8.7M urea, 1% NP-40, 20mM N-hexylmaleimide , 3mM EDTA, 10mM iodoacetamide and mixed protease inhibitors), simple sonication, 12000 rpm, centrifugation at 4°C for 20 minutes, and the supernatant was collected. Divide the sample into 2 equal parts, add to 4...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an ubiquitin E1 inhibitor and a preparation method thereof. Series compound Y-1-benzene pyrazole silane-3,5-diketone and relevant derivative (such as 4-(4-ethyoxyl-3-methoxybenzylidene)-1-benzene pyrazole silane-3,5-diketone, and the like) with different alternative groups are prepared by a liquid-phase organic synthesis method according to the structure of PRY-41(4(4-(5-nitro-furan group-methylene]-3,5-dioxo-pyrazolidine-1-radical)-ethyl benzoate). The ubiquitin E1 inhibitor can be used for inhibiting protein degradation mediated by ubiquitination and nondegradation of ubiquitination, and can kill transformed cells containing p53 in the process of blocking up the NFkB activity by the inhibitor, that is to say, the inhibitor possibly has the potential property of treating tumor and can be used as an important tool for researching ubiquitin proteinase system mechanism.

Description

technical field [0001] The invention relates to a ubiquitin E1 inhibitor compound, its derivatives and a preparation method. Background technique [0002] The ubiquitin-proteasome system (UPS), mainly includes binding enzymes (E1, E2 and E3) and a degradation complex (proteasome). E1 forms a high-energy thioester bond with the C-terminus of ubiquitin through its active cysteine, thereby activating ubiquitin. In turn, this bond is transferred to the cysteine ​​active site of E2. E3 interacts with E2, recognizes the ubiquitin that is catalyzed by the target protein, and converts the lysine residue on the target protein into an ε amino group through an isopeptide bond. The activated ubiquitin can also combine with the ubiquitin already bound to the target protein, and finally form a polyubiquitin chain. These ubiquitins can be linked via one of their seven lysines (notably K48 and K63). It has been demonstrated that ubiquitination by K48-linked polyubiquitin chains usually ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61P35/00A61K31/4152A61K31/4155A61P29/00A61P31/12A61P31/18C07D231/34A61P17/06A61P37/02C07D231/36C07D405/06
CPCY02P20/582
Inventor 刘镭李卫星王天欣
Owner 西安杰诺瓦生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com